Emergent Health Corp.: Emergent Health Subsidiary PharmaZu E

Emergent Health Corp.: Emergent Health Subsidiary PharmaZu Executes Agreement with DynaCord to Develop Various Injectable and Topical Biologic Exosomes for the Treatment of Arthritis, Joint Care, Wound Care, and Inflammation for Pets

KING OF PRUSSIA, PA / ACCESSWIRE / March 2, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces subsidiary PharmaZu executes an Agreement with DynaCord, LLC. of Baton Rouge, LA for the co-development

Related Keywords

United States , James Zimbler , Kostenloser Wertpapierhandel , Keyon Janini , Emergent Health Corp , Neuro Technology Institute , Baton Rouge , Human Exosomes , Pet Industry , Umbilical Cord Derived Mesenchymal Stem Cell , Health Corp , Emergent Health , Emergent , Health , Orp , Ubsidiary , Harmazu , Executes , Agreement , Ynacord , Evelop , Arious , Injectable , Ropical , Biologic , Exosomes , Treatment , Arthritis , Joint , Mare , Hound , Inflammation , Jets ,